Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming

Background Cardamonin, a chalcone isolated from Alpiniae katsumadai, has anti-inflammatory and anti-tumor activities. However, the molecular mechanism by which cardamonin inhibits breast cancer progression largely remains to be determined.